Seeking Alpha

R.G.Analytics

 
View R.G.Analytics' Comments BY TICKER:
  • Avanir: Addressing The Strength Of Nuedexta's Patents; Imminent Short Squeeze [View article]
    This article is not about whether Nuedexta is a block buster or not. It doesn't need to be to help a lot of people and Avanir alike. Your comment that it's a fluff is just disparaging the company which is not surprising given 26 Million shorted shares which will cause a painful short squeeze and boost the stock price up, IMO.
    Mar 2, 2012. 02:06 PM | Likes Like |Link to Comment
  • Avanir: Addressing The Strength Of Nuedexta's Patents; Imminent Short Squeeze [View article]
    With 26 Million shorted shares, no warrants, no other way out, and institutions scooping up shares, I'm not at all surprised to see these bashers spreading fear uncertainty and doubt about Avanir to get people to sell.

    << if the case is so "frivolous" that you didn't even bother to include it in your first article under the "bear case" >>

    Because even shorts know it's a frivolous case!!

    << why doesn't Avanir seek a summary judgement
    to get it thrown out with prejudice?
    How about petitioning a judge to get an injunction against the generic drug makers? >>

    You really want an answer to that stupid question Rayonman? Check with your hedge fund buddies. They'll give you the answer.

    << And the generic drug makers would not file these patent challenges if they didn't see some chance of winning. >>

    Exactly. They're taking a chance. Every person who files a frivolous case takes a chance. Even a shot in the dark has a chance.
    Mar 2, 2012. 08:59 AM | Likes Like |Link to Comment
  • Avanir: Addressing The Strength Of Nuedexta's Patents; Imminent Short Squeeze [View article]
    With 26 Million shorted shares, no warrants, no other way out, and institutions scooping up shares, I'm not at all surprised to see these bashers spreading fear uncertainty and doubt about Avanir to get people to sell.

    Here goes Rayonman, a guy who regularly goes out of his way to bash Avanir:

    << There are other possible explanations like small market size>>

    PBA market size is not small. Many surveys have been done. It's a large market and it's unserved.

    << quotes from the possible effectiveness of other drugs like SSRIs >>

    SSRI's destroyed a friend of mine recently. Nuedexta works significantly better and has significantly less side effects.

    << cardiovascular risk and the expense of Nuedexta. >>

    This is an old line from the pathetic basher Rayonman trying to scare people and get them to sell their shares. FDA has deemed Nuedexta safe and there's been no reported cardiac death like Rayonman preaches about.

    << Also it is hard to believe the projected market size of PBA... "surveys" that were not done to the caliber of medical research >>

    Ok now the pathetic puppet of short interest is accusing Avanir of having cooked up some phony survey (notice the quotes he put around surveys.

    << in my opinion>>

    Now he's trying to cover his behind after having accused the company of doing a phony survey. You can't publish that X is an alcoholic when he is not, and then say, "In my opinion".

    26 Million shorted shares. No way out except open market purchase. Short squeeze.
    Mar 2, 2012. 08:53 AM | Likes Like |Link to Comment
  • Avanir: Addressing The Strength Of Nuedexta's Patents; Imminent Short Squeeze [View article]
    You're a joke. Taking a drug to market sometimes costs one billion dollars. That's not the issue. The issue is you guys are stuck in cement with a 26 million share short position. No warrants, no sizeable calls, company has made it clear it has many choices other than dilution IF it ever needs funds (it may never), and sales growing. IMO, Shorts are and should be extremely worried.
    Mar 1, 2012. 04:47 PM | Likes Like |Link to Comment
  • Avanir: Addressing The Strength Of Nuedexta's Patents; Imminent Short Squeeze [View article]
    Good point Andy. Thanks for all your positive contributions here and on other forums. I've learned a lot from you.
    Mar 1, 2012. 01:28 PM | Likes Like |Link to Comment
  • Avanir: Addressing The Strength Of Nuedexta's Patents; Imminent Short Squeeze [View article]
    The cockroaches are out already. It just shows how terrified the 26 Million short interest is. Yesterday's news was spectacular.
    Mar 1, 2012. 01:27 PM | Likes Like |Link to Comment
  • Avanir: Addressing The Strength Of Nuedexta's Patents; Imminent Short Squeeze [View article]
    You're welcome. I believe shorts have put up a psychological war because they need to cover 26 Million shares. Institutions have been increasing their holding. Company has said it has many other options than to dilute if and when it needs funding (and that's a big if), and no call options of significant size is available. So retail is the only hope these shorts have to shake off shares from, and that explains the relentless bashing and spread of FUD and misinformation. Fortunately for us shareholders the argument of shorts is extremely weak. Look at their logic: because there's a shelf registration they're concluding that new shares will be registered. I think the company is determined to make shorts lose their shorts.
    Mar 1, 2012. 01:25 PM | Likes Like |Link to Comment
  • Avanir: Addressing The Strength Of Nuedexta's Patents; Imminent Short Squeeze [View article]
    With 26 Million shorted shares, no warrants, no sizeable call options, many alternative or no need for dilution, opposition to positive facts about Avanir is not at all surprising.
    Mar 1, 2012. 10:05 AM | 1 Like Like |Link to Comment
  • Avanir Pharmaceuticals: Limelight On The Horizon [View article]
    "Ray - you really hit a nerve here."

    Rayonman & Rimshot (a.k.a. RS Analytics) & Reetch & Bert... why so many bashers trying to spread negativity about Avanir?

    "Good companies don't need to be deceitfully pumped"

    Basher book 101 tells you Bashers don't bash bad companies.
    That was rule #1 all you bashers follow.
    Secondly, Over 26 Million shorted shares tells the whole story. No warrants left. No safety, no insurance, what will they do? Bashers might help them a bit but not much.

    Talking about deceit, bashers are the ones who have to resort to deceit. Growing sales and a product that works well and an unserved market are all facts we can talk about.

    "and don't need pump websites that present only one side of an argument".

    If you mean http://www.avnr.info -- I know it's a site shorts prefer to ignore. Truth can sometimes really hurt. Shorts made the mistake of assuming PBA is not real but it's real and Nuedexta works for a lot of other conditions too so off label could boosts sales even more going forward.

    "how retail investors can get in over their heads by over investing"

    Institutions have been buying AVNR more and more. Over 70% ownership is a strong statement of confidence. Some retail sharehoders have similar confidence.

    "anybody just trying to have a reasonable discussion about the stock"

    You mean like you and Bert write a trash piece. Both of you have admitted in being traders. Short term players can chase after pennies. Long term patient shareholders can see our shares grow. The game has just started. 1 year in the market in a new market that wasn't served before, having to educate doctors, is a short time. Some of us have a lot of patience and are not after pennies.

    "honestly discuss the pros and cons of AVNR."

    To have paid bashers traders and shorts talk about honesty is a joke. Look up Short&Distort.
    Feb 23, 2012. 05:53 PM | Likes Like |Link to Comment
  • Avanir Pharmaceuticals: Limelight On The Horizon [View article]
    "Funny how you are so paranoid about the comments of other longs like me and Rim and Bert"

    Funny how you call yourselves longs. Bert and Rim both published trash articles about Avanir and both have admitted to being traders which means chasing pennies. There are people with a lot of shares who are holding the shares for long term gain which is what the stock market is theoretically for, but of course it's turned into a Vegas. Some short term traders just trade some pretend to change their views about the stock depending on which side of the trade they're on, which means they have no character.

    Basher Handbook 101 talks about pretending to be long, and if you don't want to lie, buy a few shares, then you can say you're long, but bash the daylight out of the stock. And with 26 Million shorted shares and the freight train coming straight at them, it's not surprising to have paid bashers working overtime. Other trader-bashers help the shorts too. But this main game is between big institutions like T Row Price, Balckrock, Vanguard, Fidelity, etc., who have a growing appetite for the shares vs. a group of hedge funds who are short and made the wrong bet and have been determined to use their influence, market maker, journalist, analyst, and paid bashers to try to cap the stock, in hope of delaying the arrival of the freight train. I think the warrants were the last of the big drop in short number. Upon continued successful of the business plan, short squeeze is next. I don't think we'll see short number drop much without a significant price increase. Of course this is all my opinion.

    "Even the sell side analysts project only about $34 million in revenues this calendar year while expenses should be about $90 million."

    The ones that I know predict breakeven in 2013 and even possibly 2012 depending on how fast scripts grow and how fast Europe comes on board.

    "Meanwhile the company publicly states it is interested in buying another neurology drug which should cost at least $35 million"

    You're a liar. It does not publicly state anything to that effect. It stated it's open to it last year. This year it clearly indicated that it is NOT a priority. So only bashers with an agenda (or psychiatric illness) would use a low priority item to calculate cash position, specially given the higher priority items (growth of sales, preservation of cash) that the company has repeatedly talked about.

    "It seems clear the company's $75.4 million in cash as of 12/31/11 will not last until profitability even without an acquisition."

    That is a stupid conclusion and only a wishful reality in the heads of short seller and bashers with an agenda. Breakeven in a shorter timeframe is theoretically possible but it's not important anyway. Shorts are counting on dilution and that won't happen as I referenced Ocampo in my article.

    "I would think it will be prudent to do a secondary refinancing"

    That's what all your short buddies are hoping for so they can reduce their short interest, but bad news for you losers is stated clearly in my article -- see quote by Ocampo.

    "But the purpose of being a publicly listed company is to be able to raise the cash needed for operations."

    Only in the sick minds of you short sellers. If a public company doesn't want to kiss up to short hedge funds by using other means of financing it makes sense that it will.

    "So the easiest and most powerful and most sure thing with the least risk to the company is to raise cash by selling more stock."

    Bull! That's the best thing for shorts which your arguments represent. You've been bashing Avanir for a long time and your agenda is clear. Dream on. No dilution in the picture in 2012, IMO.

    "I would suggest directing some of your paranoia from other longs to the unrealistic vision you have of revenues, costs of operations, the coming need for refinancing, the patent challenges and the cardiovascular risks of quinidine."

    Oh baby! Bash on Rayonman with empty non-issues like CV risks -- none has been reported so far and no reason to believe it will -- patent is no issues - even your hero Wei is bullish on patent situation -- and as far as costs, they're doing a great job of controlling costs.

    Tutes are accumulating. Retails hands have gotten ever more strong, and I am not paranoid at all about you guys because the freight train will take care of it -- it's a situation shorts got themselves into and nothing can save them. Short squeeze coming up will teach shorts not to bet against companies that are trying to make the world a better place and are having a significant meaningful different in improving quality of life for patients.
    Feb 23, 2012. 06:40 AM | Likes Like |Link to Comment
  • Avanir Pharmaceuticals: Limelight On The Horizon [View article]
    I don't welcome a thief to my house just because I have a door. You have gone out of your way to spread negativity, fear uncertainty and doubt about Avanir and given 26Million shorted shares, no warrants, no call options of any size, these shorts are stuck with a bad bet which will cost them millions. So what do they do? Have people spread negativity fear uncertainty and doubt to get people to sell their shares. Institutions have accumulated over 70Million shares and seem to have appetite for more. So it's just retail shares which are sought after by shorts, market makers, and institutions who want more. And bad news for you and your buddies is company has made it clear: no dilution in the picture.
    Feb 22, 2012. 04:32 PM | Likes Like |Link to Comment
  • Avanir Pharmaceuticals: Limelight On The Horizon [View article]
    << In the two "bearish" articles you refer to one said he was a shareholder >>

    You mean a temporary shareholder who bought 4000 shares to trade to boast about a contest with his indoor sunglasses and cheap champagne? There are share holders and there are shareholders.

    "and the other said he might buy the stock within 72 hours"

    The other, you mean the guy that many people think is you, because the two of you have been bashing the hell out of Avanir. I could care less about your story Rayonman. What I know is that you've gone out of your way to spread negativity and influence people into selling their shares at historical lows. But with 26 Million shorted shares I am not surprised by any of this.

    As an author I choose what to write and am not welcoming suggestions from a proven basher who's probably working for the short interest. I don't know and I don't care. But I have zero respect for you because of your history of incessant negative propaganda against Avanir which I believe it's to help shorts. The other possibility is if you're really a shareholder you claim to be you must be totally nuts to behave like you have because it takes a real nutcase to bash his own company with bogus info lies and negativity (like your whole story with SSRI's). I can't click the ignore button here but would if I could because I don't want to have anything to do with people like you.
    Feb 21, 2012. 11:35 AM | Likes Like |Link to Comment
  • Avanir Pharmaceuticals: Limelight On The Horizon [View article]
    Rayonman, I find your constant negativity towards Avanir to correspond perfectly well with the 26+M short interest. That is my opinion, you disagree, but I'm not surprised of that either.

    As for a balanced article, how many of the short-case articles are balanced? Your buddy Rim(whom many people believe is yourself :) and Bert just posted two Bearish articles. You didn't get on their case for it not being "balanced".

    I didn't have to get past your first paragraph to see through your agenda.

    Any way you look at it Avanir shorts made a very wrong bet and they'll have to face the consequences.
    Feb 18, 2012. 06:12 PM | Likes Like |Link to Comment
  • Avanir Pharmaceuticals: Limelight On The Horizon [View article]
    Seems like every single basher is out to have their word about Avanir which is hardly surprising given the 26+M short interest. I'm not saying Rayonman you're one of them but your posting history indicates you're never short of bad things to say about Avanir. Let's see what's your latest spin?

    1) sudden cardiac death -- you've been bashing Avanir with this line for as long as I can remember. So far we haven't hears of any reports of such an event and there are thousands of patients on Nuedexta. I tend to side with the FDA that Nuedexta is safe.

    2) patents -- there are no patent issues in my opinion and in the opinion of every single analyst I've read who contents that the patents are solid. Of course you never know but as an investor this subject is absolutely no cause for my concern.
    Feb 18, 2012. 02:43 AM | Likes Like |Link to Comment
  • Avanir Pharmaceuticals: Limelight On The Horizon [View article]
    Thanks Andy for the reply. You hit the nail in the head. All these shorts who attack the company do so based on non existent negative issues. Just wait, soon they're going to criticize some executive's hair style. I've seen that happen before, when shorts completely run out of things to nag about. I've not read anything of substance so far in any of their criticism, none.
    Feb 18, 2012. 02:36 AM | Likes Like |Link to Comment
More on AVNR by R.G.Analytics
COMMENTS STATS
45 Comments
17 Likes